Education
About Us
Working with TipRanks
Follow Us
Cardinal Health (CAH)
NYSE:CAH
CAH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$106.98 - $168.44
Previous CloseN/A
Volume818.36K
Average Volume (3M)2.33M
Market Cap
$37.71B
Enterprise Value$45.94B
Total Cash (Recent Filing)$3.87B
Total Debt (Recent Filing)$8.53B
Price to Earnings (P/E)24.5
Beta0.42
Next Earnings
Oct 30, 2025EPS Estimate
2.19Last Dividend Ex-Date
Oct 01, 2025Dividend Yield1.32%
Share Statistics
EPS (TTM)2.08
Shares Outstanding238,793,640
10 Day Avg. Volume3,056,664
30 Day Avg. Volume2,332,118
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.22
Enterprise Value/Revenue0.21
Enterprise Value/Gross Profit5.62
Enterprise Value/Ebitda14.79
Forecast
1Y Price Target
$184.90Price Target Upside19.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Bulls Say, Bears Say
Bulls Say
Financial GuidanceCardinal Health's FY2026 EPS guidance has been raised due to a change in accounting for The Specialty Alliance and a slight increase in the Pharma AOI target.
Growth StrategyThe acquisition of Solaris Health expands Cardinal Health's Specialty Alliance, highlighting its multi-specialty strategy and is expected to be slightly accretive to EPS within the first 12 months post-close.
Operational PerformanceCardinal Health is well positioned to be compensated for the value the company provides given its fee-for-service contract structure amid evolving drug pricing policies.
Bears Say
Financial ConcernsAccounting dynamics impacting FY26 EPS drove a lot of questions on the call, generating hesitation with no monumental changes to the model operationally.
Pharma Segment PerformanceExpectations were high after a very robust Investor Day in June, so seeing Pharma growth below consensus feels like a bit of a letdown.
Segment PerformanceConcerns around the F4Q Pharma segment miss pressured the stock due to potential implications for future Pharma growth.
Cardinal Health News
CAH FAQ
What was Cardinal Health’s price range in the past 12 months?
Cardinal Health lowest stock price was $106.98 and its highest was $168.44 in the past 12 months.
What is Cardinal Health’s market cap?
Cardinal Health’s market cap is $37.71B.
When is Cardinal Health’s upcoming earnings report date?
Cardinal Health’s upcoming earnings report date is Oct 30, 2025 which is in 25 days.
How were Cardinal Health’s earnings last quarter?
Cardinal Health released its earnings results on Aug 12, 2025. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $2.037 by $0.043.
Is Cardinal Health overvalued?
According to Wall Street analysts Cardinal Health’s price is currently Undervalued.
Does Cardinal Health pay dividends?
Cardinal Health pays a Quarterly dividend of $0.511 which represents an annual dividend yield of 1.32%. See more information on Cardinal Health dividends here
What is Cardinal Health’s EPS estimate?
Cardinal Health’s EPS estimate is 2.19.
How many shares outstanding does Cardinal Health have?
Cardinal Health has 238,793,640 shares outstanding.
What happened to Cardinal Health’s price movement after its last earnings report?
Cardinal Health reported an EPS of $2.08 in its last earnings report, beating expectations of $2.037. Following the earnings report the stock price went down -7.21%.
Which hedge fund is a major shareholder of Cardinal Health?
Currently, no hedge funds are holding shares in CAH
Cardinal Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$184.90 (19.71% Upside)
$184.90 (19.71% Upside)
Blogger Sentiment
Bullish
CAH Sentiment 80%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 239.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $90.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.7%
Last 30 Days ▼ 4.4%
Last 30 Days ▼ 4.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
41.98%
12-Months-Change
Fundamentals
Return on Equity
-43.80%
Trailing 12-Months
Asset Growth
17.73%
Trailing 12-Months
Company Description
Cardinal Health
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
CAH Company Deck
CAH Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance, strategic acquisitions, and growth in several business segments. However, it also acknowledged challenges with SG&A expenses and tariff impacts. Overall, the positives slightly outweigh the negatives.View all CAH earnings summariesCAH Revenue Breakdown
91.94% Pharmaceutical and Specialty Solutions
5.68% Global Medical Products and Distribution
2.42% Other
CAH Stock 12 Month Forecast
Average Price Target
$184.90
▲(19.71% Upside)
Technical Analysis
Ownership Overview
0.24% Insiders
22.01% Mutual Funds
13.21% Other Institutional Investors
36.02% Public Companies and Individual Investors